Immune Profiling Core
免疫分析核心
基本信息
- 批准号:9980787
- 负责人:
- 金额:$ 46.12万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-08-15 至 2022-07-31
- 项目状态:已结题
- 来源:
- 关键词:Adjuvant TherapyAntibodiesAntigensAutopsyB-LymphocytesBiological AssayBiological Specimen BanksBiopsyBody FluidsCatalogsCell DeathCellsChairpersonClinicalColorCommunicable DiseasesCore FacilityCryopreservationCytomegalovirusEnvironmentFlow CytometryHealth Services ResearchHistologyHumanHuman Herpesvirus 4ImmuneImmunizationImmunoassayImmunocompromised HostImmunohistochemistryImmunologicsImmunologyImmunology procedureIndividualInfrastructureKidney TransplantationKnowledgeLaboratoriesLasersLeadLeadershipLymphocryptovirusMacaca mulattaManagement Information SystemsMemory B-LymphocyteMonitorOperative Surgical ProceduresPeripheral Blood Mononuclear CellPhenotypePlasmaPlasma CellsPositioning AttributePrior TherapyProceduresProteasome InhibitionRegimenRegulationResearchResearch SupportResource SharingRhesusRiskSafetySamplingScientistSerumServicesSimian virus 40SirolimusSpecimenSpecimen HandlingStainsStandardizationStructure of germinal center of lymph nodeSupervisionT-LymphocyteTechnical ExpertiseTestingThymus GlandTissue SampleTissuesTransplantationUniversitiesViralViral AntigensVirus LatencyWorkbasebiobankclinically relevantcytokinedesensitizationdigitalexhaustioninstrumentkidney allograftlaboratory experiencelymph nodesmedical schoolsnonhuman primatepost-transplantpreventprogramsquality assuranceresearch studysecondary lymphoid organsingle cell analysissynergismtesting servicesvirology
项目摘要
ABSTRACT – Immune Profiling Core
The Immune Profiling Core (IPC) will provide comprehensive technical assay support services for the
hypothesis-driven research studies proposed in the two Projects comprising this U19 proposal. The Core
derives its greatest overall strength from the relevant expertise, organization, procedures, and operational
synergy of its components. Anchoring these efforts is the Duke Immune Profiling Core (DIPC), a Duke School
of Medicine Shared Resource that has been in existence since 1988. Largely focused on flow cytometry-based
platforms for human immune profiling, the Core has actively participated in external proficiency testing and
quality assurance programs for over 25 years. Assay testing is performed in a Good Clinical Laboratory
(GCLP)-compliant environment according to highly standardized and validated Standard Operating Procedures
(SOPs). The Core is joined in its efforts by a support team of highly experienced laboratory professionals from
the Kirk and Knechtle research Cores who have recently re-located to Duke from Emory University. These
individuals have extensive expertise in all aspects of transplantation research, both in human and nonhuman
primate (NHP) studies. The key services the IPC will provide to Projects 1 and 2 include: 1) state-of-the-art
specimen processing and biobanking, 2) analytical polychromatic flow cytometry (PFC) phenotyping, and
intracellular cytokine staining (ICCS), 3) virologic testing, and 4) comprehensive histology and
immunohistochemistry support. The IPC is well positioned to provide PFC services to the projects under this
proposal; PFC having been the technical mainstay of the research endeavors of the DIPC. The present core
facility houses a 4-laser BD LSRII, 5-laser BD LSRFortessa, 5-laser BD LSR-X20 and, most recently, a 5-laser
BD LSR-X50. Of these digital instruments, the first 3 are capable of up to 18-24 parameter single cell analyses,
while the X50 is capable of supporting 50-parameter flow cytometry. To provide comprehensive immunologic
support, we have implemented several highly developed components for the IPC. A specimen processing and
biobanking service that began at Emory under Dr. Kirk has been re-established as the Substrate Services and
Research Support Service (SSCRSS) at Duke following his arrival as Chairman of the Department of Surgery.
Through the work of Dr. Kirk's laboratory, we have also established a viral testing facility that will allow the IPC
to monitor three of the most clinically-relevant latent viruses in NHPs: Rhesus Cytomegalovirus (rhCMV),
Rhesus Lymphocryptovirus (rhLCV) (rhesus homology of EBV), and Simian Virus 40 (SV40). The IPC will
provide routine histology and immunohistochemistry assays through our immunohistochemistry service
laboratory, which will allow each project to examine the effects of the experimental manipulations on key host
tissue. Special emphasis will be placed on examining effects on germinal center formation following the various
induction regimens. The juxtaposition of human and NHP expertise represents a particular strength of this IPC
consortium, further facilitating the highly translational aspects of the proposed studies.
摘要 - 免疫分析核心
免疫分析核心(IPC)将为
假设驱动的研究在完成了U19提案的两个项目中提出的研究。核心
从相关的专业知识,组织,程序和运营中获得最大的总体优势
其组件的协同作用。锚定这些努力的是杜克大学杜克大学免疫分析核心(DIPC)
自1988年以来一直存在的医学共享资源。
人类免疫分析平台,核心已经积极参与外部能力测试和
质量保证计划超过25年。测定测试是在良好的临床实验室中进行的
(GCLP) - 根据高标准化和经过验证的标准操作程序重编的环境
(SOP)。由经验丰富的实验室专业人员的支持团队加入了核心的努力
最近从埃默里大学(Emory University)重新安置到杜克大学(Duke)的柯克(Kirk)和克尼克(Knechtle)研究核心。这些
个人在人类和非人类的移植研究的各个方面都有广泛的专业知识
灵长类动物(NHP)研究。 IPC将向项目1和2提供的关键服务包括:1)
标本加工和生物群,2)分析多色流式细胞仪(PFC)表型和
细胞内细胞因子染色(ICC),3)病毒学测试,4)综合组织学和
免疫组织化学支持。 IPC的位置很好,可以为此提供PFC服务
提议; PFC是DIPC研究努力的技术中流tay柱。现在的核心
设施设有4射线BD LSRII,5射线BD LSRFORTESSA,5-LASER BD LSR-X20,以及最近的5-laser
BD LSR-X50。在这些数字仪器中,前3个最多能够进行18-24个参数单细胞分析,
X50能够支持50参数流式细胞仪。提供全面的免疫学
支持,我们已经为IPC实施了几个高度开发的组件。标本处理和
Kirk博士从Emory开始的生物库服务已被重新建立为基板服务,并且
杜克大学(Duke)的研究支持服务(SSCRSS)在他担任外科部主席后。
通过柯克博士的实验室的工作,我们还建立了一个病毒测试设施,将允许IPC
监测NHP中三种最临床中最相关的潜在病毒:恒河猴(RHCMV),
恒河-淋巴结病毒(Rhlcv)(EBV的恒河类同源性)和猿猴病毒40(SV40)。 IPC会
通过我们的免疫组织化学服务提供常规的组织学和免疫组织化学测定
实验室,这将允许每个项目检查实验操作对关键主机的影响
组织。特殊重点将放在检查对各种生发中心形成的影响之上
诱导方案。人类和NHP专业知识的并置代表了此IPC的特殊优势
财团,进一步促进了拟议研究的高度翻译方面。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kent J. Weinhold其他文献
Preparation and characterization of an intravenous solution of IgG from human immunodeficiency virus-seropositive donors.
来自人类免疫缺陷病毒血清阳性供体的 IgG 静脉注射溶液的制备和表征。
- DOI:
10.1182/blood.v77.5.1111.bloodjournal7751111 - 发表时间:
1991 - 期刊:
- 影响因子:20.3
- 作者:
Larry M. Cummins;Kent J. Weinhold;Thomas J. Matthews;A. J. Langlois;C. F. Perno;RICHARD M. Condie;Jean - 通讯作者:
Jean
Characteristics of a neutralizing monoclonal antibody to the HIV envelope glycoprotein.
HIV 包膜糖蛋白中和单克隆抗体的特征。
- DOI:
- 发表时间:
1988 - 期刊:
- 影响因子:1.5
- 作者:
Michael A. Skinner;Robert Ting;A. J. Langlois;Kent J. Weinhold;H. K. Lyerly;K. Javaherian;Thomas J. Matthews - 通讯作者:
Thomas J. Matthews
3'-Azido-3'-deoxythymidine triphosphate as an inhibitor and substrate of purified human immunodeficiency virus reverse transcriptase
3-叠氮基-3-脱氧胸苷三磷酸作为纯化人免疫缺陷病毒逆转录酶的抑制剂和底物
- DOI:
10.1128/aac.31.12.1972 - 发表时间:
1987 - 期刊:
- 影响因子:4.9
- 作者:
M. H. S. Clair;Cynthia A. Richards;Thomas Spector;Kent J. Weinhold;Wayne H. Miller;A. J. Langlois;Phillip A. Furman - 通讯作者:
Phillip A. Furman
Measurement of direct and indirect forms of anti-HIV-1 ADCC: implications for other retroviral disease.
抗 HIV-1 ADCC 的直接和间接形式的测量:对其他逆转录病毒疾病的影响。
- DOI:
- 发表时间:
1990 - 期刊:
- 影响因子:0
- 作者:
Kent J. Weinhold;Douglas S. Tyler;H. K. Lyerly - 通讯作者:
H. K. Lyerly
Coupling Hematoma Evacuation with Immune Profiling for Analysis of Neuroinflammation After Primary Intracerebral Hemorrhage: A Pilot Study
- DOI:
10.1016/j.wneu.2022.02.062 - 发表时间:
2022-05-01 - 期刊:
- 影响因子:
- 作者:
Jay B. Lusk;Quintin J. Quinones;Janet S. Staats;Kent J. Weinhold;Peter M. Grossi;Shahid M. Nimjee;Daniel T. Laskowitz;Michael L. James - 通讯作者:
Michael L. James
Kent J. Weinhold的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kent J. Weinhold', 18)}}的其他基金
Biorepository, Pathology, and Immune Monitoring Core
生物样本库、病理学和免疫监测核心
- 批准号:
10248315 - 财政年份:2014
- 资助金额:
$ 46.12万 - 项目类别:
Biorepository, Pathology, and Immune Monitoring Core
生物样本库、病理学和免疫监测核心
- 批准号:
10705239 - 财政年份:2014
- 资助金额:
$ 46.12万 - 项目类别:
相似国自然基金
抗变构/单体形式的C反应蛋白关键抗原表位199-206抗体在狼疮性肾炎小管间质病变中的作用机制及其靶向治疗研究
- 批准号:82300829
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
原位疫苗新策略:抗体偶联仿生ROS纳米酶增强巨噬细胞吞噬及抗原交叉呈递效应
- 批准号:32371454
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
基于抗原抗体相互作用的抗体定向虚拟设计与筛选
- 批准号:32370697
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
单个抗体IgG在图案化抗原阵列上运动的可视化研究
- 批准号:32301180
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
CD40-CD154共刺激信号介导的TD/TI抗原诱导罗非鱼抗体分泌细胞形成机制的比较研究
- 批准号:32303044
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
A Novel Sublingual Vaccine to Prevent Neisseria Gonorrhoeae Infection
预防淋病奈瑟菌感染的新型舌下疫苗
- 批准号:
10699065 - 财政年份:2023
- 资助金额:
$ 46.12万 - 项目类别:
Genetic adjuvants to elicit neutralizing antibodies against HIV
基因佐剂可引发抗艾滋病毒中和抗体
- 批准号:
10491642 - 财政年份:2023
- 资助金额:
$ 46.12万 - 项目类别:
Validation of the joint-homing and drug delivery attributes of novel peptides in a mouse arthritis model
在小鼠关节炎模型中验证新型肽的关节归巢和药物递送特性
- 批准号:
10589192 - 财政年份:2023
- 资助金额:
$ 46.12万 - 项目类别:
Project 2: Mechanisms of Resistance to Neoantigen Vaccines in PDAC
项目2:PDAC新抗原疫苗耐药机制
- 批准号:
10708575 - 财政年份:2023
- 资助金额:
$ 46.12万 - 项目类别:
Defining Optimal Radiotherapy Dose and Fractionation in Combination with Preoperative Immuno-Chemotherapy in Early-Stage Triple Negative Breast Cancer
确定早期三阴性乳腺癌的最佳放疗剂量和分割与术前免疫化疗相结合
- 批准号:
10512391 - 财政年份:2023
- 资助金额:
$ 46.12万 - 项目类别: